In vitro sensitivity of Plasmodium falciparum clinical isolates from the China-Myanmar border area to quinine and association with polymorphism in the Na+/H+ exchanger

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 10, 2010, Pages 4306-4313

  Meng, Hao ^a   Zhang, Rongping ^a   Yang, Henglin ^b   Fan, Qi ^a,c   Su, Xinzhuan ^d   Miao, Jun ^e   Cui, Liwang ^e   Yang, Zhaoqing ^a  

^a KUNMING MEDICAL UNIVERSITY   (China)

^b Yunnan Institute of Parasitic Diseases   (China)

^c LIAONING ACADEMY OF AGRICULTURAL SCIENCES   (China)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA MINISATELLITE; MULTIDRUG RESISTANCE PROTEIN 1; QUININE;

ANTIMALARIAL DRUG RESISTANCE; ANTIMALARIAL DRUG SUSCEPTIBILITY; ARTICLE; CHINA; DNA POLYMORPHISM; GENE AMPLIFICATION; GENE MUTATION; HAPLOTYPE; IC 50; IN VITRO STUDY; MYANMAR; NONHUMAN; PARASITE ISOLATION; PFNHE1 GENE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

ANTIMALARIALS; CHINA; MEMBRANE TRANSPORT PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROTOZOAN PROTEINS; QUININE; SODIUM-HYDROGEN ANTIPORTER;

EID: 77957331643     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00321-10     Document Type: Article

References (51)

1. + exchanger (Pfnhe-1) gene with reduced in vitro susceptibility to quinine: lack of confirmation in clinical isolates from Africa. Am. J. Trop. Med. Hyg. 82:782-787.
2. Baniecki, M. L., D. F. Wirth, and J. Clardy. 2007. High-throughput Plasmodium falciparum growth assay for malaria drug discovery. Antimicrob. Agents Chemother. 51:716-723.
3. Basco, L. K., and P. Ringwald. 2002. Molecular epidemiology of malaria in Cameroon. X. Evaluation of PFMDR1 mutations as genetic markers for resistance to amino alcohols and artemisinin derivatives. Am. J. Trop. Med. Hyg. 66:667-671.
4. + exchanger activity and quinine resistance. Mol. Biochem. Parasitol. 153:48-58.
5. Brasseur, P., J. Kouamouo, R. Moyou-Somo, and P. Druilhe. 1992. Multidrug resistant falciparum malaria in Cameroon in 1987-1988. I. Stable figures of prevalence of chloroquine- and quinine-resistant isolates in the original foci. Am. J. Trop. Med. Hyg. 46:1-7.
6. Cooper, R. A., M. T. Ferdig, X. Z. Su, L. M. Ursos, J. Mu, T. Nomura, H. Fujioka, D. A. Fidock, P. D. Roepe, and T. E. Wellems. 2002. Alternative mutations at position 76 of the vacuolar transmembrane protein PfCRT are associated with chloroquine resistance and unique stereospecific quinine and quinidine responses in Plasmodium falciparum. Mol. Pharmacol. 61:35-42.
7. Cooper, R. A., K. D. Lane, B. Deng, J. Mu, J. J. Patel, T. E. Wellems, X. Su, and M. T. Ferdig. 2007. Mutations in transmembrane domains 1, 4 and 9 of the Plasmodium falciparum chloroquine resistance transporter alter susceptibility to chloroquine, quinine and quinidine. Mol. Microbiol. 63:270-282.
8. Cowman, A. F., D. Galatis, and J. K. Thompson. 1994. Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine. Proc. Natl. Acad. Sci. U. S. A. 91:1143-1147.
9. Ferdig, M. T., R. A. Cooper, J. Mu, B. Deng, D. A. Joy, X. Z. Su, and T. E. Wellems. 2004. Dissecting the loci of low-level quinine resistance in malaria parasites. Mol. Microbiol. 52:985-997.
10. Fidock, D. A., T. Nomura, A. K. Talley, R. A. Cooper, S. M. Dzekunov, M. T. Ferdig, L. M. Ursos, A. B. Sidhu, B. Naude, K. W. Deitsch, X. Z. Su, J. C. Wootton, P. D. Roepe, and T. E. Wellems. 2000. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol. Cell 6:861-871.
11. Foote, S. J., D. E. Kyle, R. K. Martin, A. M. Oduola, K. Forsyth, D. J. Kemp, and A. F. Cowman. 1990. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature 345:255-258.
12. Giboda, M., and M. B. Denis. 1988. Response of Kampuchean strains of Plasmodium falciparum to antimalarials: in-vivo assessment of quinine and quinine plus tetracycline; multiple drug resistance in vitro. J. Trop. Med. Hyg. 91:205-211.
13. + exchanger 1 transporter is involved in reduced susceptibility to quinine. Antimicrob. Agents Chemother. 53:1926-1930.
14. Jelinek, T., P. Schelbert, T. Loscher, and D. Eichenlaub. 1995. Quinine resistant falciparum malaria acquired in east Africa. Trop. Med. Parasitol. 46:38-40.
15. Kaneko, O., M. Kimura, F. Kawamoto, M. U. Ferreira, and K. Tanabe. 1997. Plasmodium falciparum: allelic variation in the merozoite surface protein 1 gene in wild isolates from southern Vietnam. Exp. Parasitol. 86:45-57.
16. Mittra, P., S. Vinayak, H. Chandawat, M. K. Das, N. Singh, S. Biswas, V. Dev, A. Kumar, M. A. Ansari, and Y. D. Sharma. 2006. Progressive increase in point mutations associated with chloroquine resistance in Plasmodium falciparum isolates from India. J. Infect. Dis. 193:1304-1312.
17. Mockenhaupt, F. P. 1995. Mefloquine resistance in Plasmodium falciparum. Parasitol. Today 11:248-253.
18. Mu, J., M. T. Ferdig, X. Feng, D. A. Joy, J. Duan, T. Furuya, G. Subramanian, L. Aravind, R. A. Cooper, J. C. Wootton, M. Xiong, and X. Z. Su. 2003. Multiple transporters associated with malaria parasite responses to chloroquine and quinine. Mol. Microbiol. 49:977-989.
19. Nkrumah, L. J., P. M. Riegelhaupt, P. Moura, D. J. Johnson, J. Patel, K. Hayton, M. T. Ferdig, T. E. Wellems, M. H. Akabas, and D. A. Fidock. 2009. Probing the multifactorial basis of Plasmodium falciparum quinine resistance: evidence for a strain-specific contribution of the sodium-proton exchanger PfNHE. Mol. Biochem. Parasitol. 165:122-131.
20. Olliaro, P. 2005. Drug resistance hampers our capacity to roll back malaria. Clin. Infect. Dis. 41(Suppl. 4):S247-257.
21. Pettinelli, F., M. E. Pettinelli, P. Eldin de Pecoulas, J. Millet, D. Michel, P. Brasseur, and P. Druilhe. 2004. Short report. High prevalence of multidrug-resistant Plasmodium falciparum malaria in the French territory of Mayotte. Am. J. Trop. Med. Hyg. 70:635-637.
22. Pickard, A. L., C. Wongsrichanalai, A. Purfield, D. Kamwendo, K. Emery, C. Zalewski, F. Kawamoto, R. S. Miller, and S. R. Meshnick. 2003. Resistance to antimalarials in Southeast Asia and genetic polymorphisms in pfmdr1. Antimicrob. Agents Chemother. 47:2418-2423.
23. Pradines, B., T. Pistone, K. Ezzedine, S. Briolant, L. Bertaux, M. C. Receveur, D. Parzy, P. Millet, C. Rogier, and D. Malvy. 2010. Quinine-resistant malaria in traveler returning from Senegal, 2007. Emerg. Infect. Dis. 16:546-548.
24. Price, R. N., C. Cassar, A. Brockman, M. Duraisingh, M. van Vugt, N. J. White, F. Nosten, and S. Krishna. 1999. The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand. Antimicrob. Agents Chemother. 43:2943-2949.
25. Price, R. N., A. C. Uhlemann, A. Brockman, R. McGready, E. Ashley, L. Phaipun, R. Patel, K. Laing, S. Looareesuwan, N. J. White, F. Nosten, and S. Krishna. 2004. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 364:438-447.
26. Pukrittayakamee, S., W. Supanaranond, S. Looareesuwan, S. Vanijanonta, and N. J. White. 1994. Quinine in severe falciparum malaria: evidence of declining efficacy in Thailand. Trans. R. Soc. Trop. Med. Hyg. 88:324-327.
27. Raj, D. K., J. Mu, H. Jiang, J. Kabat, S. Singh, M. Sullivan, M. P. Fay, T. F. McCutchan, and X. Z. Su. 2009. Disruption of a Plasmodium falciparum multidrug resistance-associated protein (PfMRP) alters its fitness and transport of antimalarial drugs and glutathione. J. Biol. Chem. 284:7687-7796.
28. Ralaimazava, P., R. Durand, N. Godineau, A. Keundjian, Z. Jezic, B. Pradines, O. Bouchaud, and J. Le Bras. 2002. Profile and evolution of the chemosusceptibility of falciparum malaria imported into France in 2000. Euro Surveill. 7:113-118.
29. Rathod, P. K., T. McErlean, and P. C. Lee. 1997. Variations in frequencies of drug resistance in Plasmodium falciparum. Proc. Natl. Acad. Sci. U. S. A. 94:9389-9393.
30. Reed, M. B., K. J. Saliba, S. R. Caruana, K. Kirk, and A. F. Cowman. 2000. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 403:906-909.
31. Roper, C., W. Richardson, I. M. Elhassan, H. Giha, L. Hviid, G. M. Satti, T. G. Theander, and D. E. Arnot. 1998. Seasonal changes in the Plasmodium falciparum population in individuals and their relationship to clinical malaria: a longitudinal study in a Sudanese village. Parasitology 116:501-510.
32. Sattabongkot, J., T. Tsuboi, G. E. Zollner, J. Sirichaisinthop, and L. Cui. 2004. Plasmodium vivax transmission: chances for control? Trends Parasitol. 20:192-198.
33. Segurado, A. A., S. M. di Santi, and M. Shiroma. 1997. In vivo and in vitro Plasmodium falciparum resistance to chloroquine, amodiaquine and quinine in the Brazilian Amazon. Rev. Inst. Med. Trop. Sao Paulo 39:85-90.
34. Sidhu, A. B., A. C. Uhlemann, S. G. Valderramos, J. C. Valderramos, S. Krishna, and D. A. Fidock. 2006. Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. J. Infect. Dis. 194:528-535.
35. Sidhu, A. B., S. G. Valderramos, and D. A. Fidock. 2005. pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. Mol. Microbiol. 57:913-926.
36. Smilkstein, M., N. Sriwilaijaroen, J. X. Kelly, P. Wilairat, and M. Riscoe. 2004. Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob. Agents Chemother. 48:1803-1806.
37. Snounou, G., X. Zhu, N. Siripoon, W. Jarra, S. Thaithong, K. N. Brown, and S. Viriyakosol. 1999. Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. Trans. R. Soc. Trop. Med. Hyg. 93:369-374.
38. Socheat, D., M. B. Denis, T. Fandeur, Z. Zhang, H. Yang, J. Xu, X. Zhou, S. Phompida, R. Phetsouvanh, S. Lwin, K. Lin, T. Win, S. W. Than, Y. Htut, S. Prajakwong, C. Rojanawatsirivet, R. Tipmontree, S. Vijaykadga, S. Konchom, D. Cong le, N. T. Thien, K. Thuan le, P. Ringwald, A. Schapira, E. Christophel, K. Palmer, P. R. Arbani, C. Prasittisuk, R. Rastogi, F. Monti, C. Urbani, R. Tsuyuoka, S. Hoyer, L. Otega, K. Thimasarn, S. Songcharoen, J. P. Meert, F. Gay, L. Crissman, N. Cho Min, W. Chansuda, D. Darasri, K. Indaratna, P. Singhasivanon, S. Chuprapawan, S. Looareesuwan, S. Supavej, C. Kidson, V. Baimai, S. Yimsamran, and K. Buchachart. 2003. Mekong malaria. II. Update of malaria, multi-drug resistance and economic development in the Mekong region of Southeast Asia. Southeast Asian J. Trop. Med. Public Health 34(Suppl. 4):1-102.
39. Uhlemann, A. C., and S. Krishna. 2005. Antimalarial multi-drug resistance in Asia: mechanisms and assessment. Curr. Top. Microbiol. Immunol. 295:39-53.
40. + exchanger 1 transporter protein implicated in quinine resistance. Antimicrob. Agents Chemother. 51:4508-4511.
41. White, N. 1999. Antimalarial drug resistance and combination chemotherapy. Philos. Trans. R. Soc. Lond. B Biol. Sci. 354:739-749.
42. WHO. 2009. Development of a strategy towards elimination of Plasmodium falciparum parasites with altered response to artemisinins. World Health Organization, Geneva, Switzerland.
43. WHO. 2009. World malaria report 2009. World Health Organization, Geneva, Switzerland.
44. Wilson, C. M., S. K. Volkman, S. Thaithong, R. K. Martin, D. E. Kyle, W. K. Milhous, and D. F. Wirth. 1993. Amplification of pfmdr 1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand. Mol. Biochem. Parasitol. 57:151-160.
45. Winstanley, P. 2001. Modern chemotherapeutic options for malaria. Lancet Infect. Dis. 1:242-250.
46. Wongsrichanalai, C., A. L. Pickard, W. H. Wernsdorfer, and S. R. Meshnick. 2002. Epidemiology of drug-resistant malaria. Lancet Infect. Dis. 2:209-218.
47. Yang, H. 1997. Plasmodium falciparum malaria in Yunnan: surveillance and control. Chin. J. Parasit. Dis. Control 10:63-64.
48. Yang, H., P. Yang, and Y. Yang. 1994. In vitro sensitivity of Plasmodium falciparum to mefloquine, quinine, amodiaquine, chloroquine, pyronaridine and sulfadoxine/pyrimethamine in south Yunnan. Chin. J. Parasitol. Parasit. Dis. 12:140-142.
49. Yang, H. L., D. Q. Liu, Y. M. Yang, K. G. Huang, Y. Dong, P. F. Yang, M. Z. Liao, and C. Y. Zhang. 1997. In vitro sensitivity of Plasmodium falciparum to eight antimalarials in China-Myanmar and China-Lao PDR border areas. Southeast Asian J. Trop. Med. Public Health 28:460-464.
50. Yang, Z., Z. Zhang, X. Sun, W. Wan, L. Cui, X. Zhang, D. Zhong, G. Yan, and L. Cui. 2007. Molecular analysis of chloroquine resistance in Plasmodium falciparum in Yunnan Province, China. Trop. Med. Int. Health 12:1051-1060.
51. Zalis, M. G., L. Pang, M. S. Silveira, W. K. Milhous, and D. F. Wirth. 1998. Characterization of Plasmodium falciparum isolated from the Amazon region of Brazil: evidence for quinine resistance. Am. J. Trop. Med. Hyg. 58:630-637.